Literature DB >> 33412996

Clinical Course and Risk Factors of Disease Deterioration in Critically Ill Patients with COVID-19.

Weidong Qin1, Wenwu Bai2, Keyin Liu3, Ya Liu4, Xiao Meng4,5, Kai Zhang4,5, Mingxiang Zhang5.   

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in December 2019 and rapidly spread to other provinces in China as well as other countries. In this study, 262 patients diagnosed with moderate to severe SARS-CoV-2 pneumonia in Wuhan, China, were analyzed. Data were compared between survivors and nonsurvivors. Of all the 262 patients, 23 (8.8%) patients died and 239 (91.2%) were discharged. The median age was 63.5 years and 46.9% of patients were male. The main complaints were fever (83.6%), cough (63.4%), and fatigue (49.2%) in the surviving group, while there were more complaints of dyspnea (39.1%) and shortness of breath (56.5%) in the nonsurviving group. The main comorbidities were hypertension (35.5%), diabetes mellitus (16.4%), and coronary artery disease (9.9%). Morbidity is higher in elderly patients with more comorbidities. Patients were mainly treated with nasal cannula (93.9%), while the nonsurviving group received more invasive mechanical ventilation (39.1%). Arbidol (80.9%), ribavirin (36.6%), oseltamivir (38.9%), interferon (16.4%), and ganciclovir (14.5%) were used for the antiviral treatment. In the nonsurviving group, the number of white blood cells (WBC) was significantly increased and lymphocytes were decreased, and lymphopenia was more common. The levels of aspartate transaminase (AST), brain natriuretic peptide (BNP), creatine kinase isoenzyme MB (CK-MB), lactate dehydrogenase (LDH), and C-reactive protein (CRP) were also significantly increased in the nonsurviving group. The adjusted hazard ratios (HRs) for association of known variables for all-cause mortality due to the coronavirus disease 2019 were 2.467 (95% confidence interval [CI], 1.007-6.044; p = 0.048) for shortness of breath and 1.025 (95% CI, 1.001-1.049; p = 0.042) for AST. Elderly patients with more comorbidities and complaints of dyspnea and shortness of breath had increased risk of death. Patients with lymphopenia and high levels of WBC, AST, BNP, CK-MB, LDH, and CRP may be more likely to deteriorate.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; blood test; clinical characteristics; treatments

Year:  2021        PMID: 33412996     DOI: 10.1089/hum.2020.255

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  8 in total

Review 1.  Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Abraham Degarege; Zaeema Naveed; Josiane Kabayundo; David Brett-Major
Journal:  Pathogens       Date:  2022-05-10

Review 2.  Molecular Mechanism of Induction of Bone Growth by the C-Type Natriuretic Peptide.

Authors:  Estera Rintz; Grzegorz Węgrzyn; Toshihito Fujii; Shunji Tomatsu
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

3.  Clinical features and predictors of mortality among hospitalized patients with COVID-19 in Niger.

Authors:  Patrick D M C Katoto; Issoufou Aboubacar; Batouré Oumarou; Eric Adehossi; Blanche-Philomene Melanga Anya; Aida Mounkaila; Adamou Moustapha; El Khalef Ishagh; Gbaguidi Aichatou Diawara; Biey Joseph Nsiari-Muzeyi; Tambwe Didier; Charles Shey Wiysonge
Journal:  Confl Health       Date:  2021-12-14       Impact factor: 2.723

Review 4.  Complement activation in COVID-19 and targeted therapeutic options: A scoping review.

Authors:  Endry Hartono Taslim Lim; Rombout Benjamin Ezra van Amstel; Vieve Victoria de Boer; Lonneke Alette van Vught; Sanne de Bruin; Matthijs Christian Brouwer; Alexander Petrus Johannes Vlaar; Diederik van de Beek
Journal:  Blood Rev       Date:  2022-07-30       Impact factor: 10.626

5.  B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.

Authors:  Angelo Zinellu; Salvatore Sotgia; Ciriaco Carru; Arduino A Mangoni
Journal:  Front Cardiovasc Med       Date:  2021-06-24

Review 6.  Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression.

Authors:  Angelo Zinellu; Salvatore Sotgia; Alessandro G Fois; Arduino A Mangoni
Journal:  Adv Med Sci       Date:  2021-07-07       Impact factor: 3.287

Review 7.  Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.

Authors:  Rundong Qin; Li He; Zhaowei Yang; Nan Jia; Ruchong Chen; Jiaxing Xie; Wanyi Fu; Hao Chen; Xinliu Lin; Renbin Huang; Tian Luo; Yukai Liu; Siyang Yao; Mei Jiang; Jing Li
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-18       Impact factor: 10.817

8.  Age Dependent Epidemic Modeling of COVID-19 Outbreak in Kuwait, France, and Cameroon.

Authors:  Kayode Oshinubi; Sana S Buhamra; Noriah M Al-Kandari; Jules Waku; Mustapha Rachdi; Jacques Demongeot
Journal:  Healthcare (Basel)       Date:  2022-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.